Andrew J Dannenberg Selected Research

Aromatase (CYP19)

1/2022	Retraction: Obesity Is Associated With Inflammation and Elevated Aromatase Expression in the Mouse Mammary Gland.
3/2021	Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations.
1/2021	Effects of Adiposity and Exercise on Breast Tissue and Systemic Metabo-Inflammatory Factors in Women at High Risk or Diagnosed with Breast Cancer.
1/2020	Withdrawal: EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells: Evidence of a BRCA1 and p300 exchange.
1/2020	Withdrawal: Hsp90 and PKM2 drive the expression of aromatase in Li-Fraumeni syndrome breast adipose stromal cells.
1/2019	Prostaglandin E2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection.
1/2018	Adiposity, Inflammation, and Breast Cancer Pathogenesis in Asian Women.
1/2018	A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.
1/2018	FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
4/2017	Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew J Dannenberg Research Topics

Disease

69	Neoplasms (Cancer) 01/2022 - 01/2002
42	Inflammation (Inflammations) 01/2022 - 01/2003
40	Obesity 01/2022 - 03/2011
39	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2002
36	Carcinogenesis 01/2021 - 03/2002
10	Colitis 01/2021 - 09/2006
9	Colonic Neoplasms (Colon Cancer) 01/2022 - 06/2002
8	Insulin Resistance 01/2022 - 01/2013
7	Squamous Cell Carcinoma of Head and Neck 01/2016 - 08/2002
6	Weight Loss (Weight Reduction) 01/2022 - 11/2013
6	Overweight 01/2020 - 07/2011
6	Oral Leukoplakia 04/2012 - 08/2002
5	Body Weight (Weight, Body) 01/2022 - 08/2008
5	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2002
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2004
4	Li-Fraumeni Syndrome 01/2020 - 03/2014
3	Fibrosis (Cirrhosis) 01/2021 - 08/2015
3	Barrett Esophagus (Barrett's Esophagus) 01/2019 - 04/2004
3	Pain (Aches) 01/2019 - 10/2003
3	Hypertrophy 01/2018 - 04/2013
3	Weight Gain 01/2018 - 08/2015
3	Lung Neoplasms (Lung Cancer) 01/2016 - 09/2008
3	Adenoma (Adenomas) 12/2012 - 08/2006
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 04/2007 - 02/2003
2	Crohn Disease (Crohn's Disease) 01/2021 - 02/2006
2	Infections 01/2021 - 01/2012
2	COVID-19 12/2020 - 01/2020
2	Atherosclerosis 10/2018 - 01/2007
2	Atherosclerotic Plaque (Atheroma) 10/2018 - 02/2006
2	Polyps 09/2016 - 02/2003
2	Pneumonia (Pneumonitis) 12/2015 - 04/2009
2	Pathologic Processes 01/2014 - 12/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2013 - 04/2009

Drug/Important Bio-Agent (IBA)

31	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 05/2002
23	Aromatase (CYP19)IBA 01/2022 - 05/2006
21	ProstaglandinsIBA 01/2019 - 08/2002
18	Dinoprostone (PGE2)FDA Link 01/2019 - 10/2002
17	Hormones (Hormone)IBA 01/2019 - 05/2004
16	Estrogens (Estrogen)FDA Link 01/2019 - 05/2004
15	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2016 - 06/2002
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2006
14	EnzymesIBA 01/2021 - 08/2002
12	Proteins (Proteins, Gene)FDA Link 05/2021 - 05/2002
11	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2013 - 01/2002
11	Prostaglandins EIBA 04/2012 - 08/2003
10	Celecoxib (Celebrex)FDA Link 09/2016 - 10/2002
10	SmokeIBA 02/2014 - 01/2005
7	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021 - 09/2006
7	Dextrans (Dextran)FDA Link 01/2021 - 09/2006
7	Messenger RNA (mRNA)IBA 01/2012 - 08/2003
6	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 03/2002
6	C-Reactive ProteinIBA 01/2021 - 01/2016
6	Prostaglandin-E SynthasesIBA 01/2020 - 08/2003
6	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 01/2016 - 08/2005
6	Pharmaceutical PreparationsIBA 11/2013 - 06/2006
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 07/2004
5	AzoxymethaneIBA 01/2021 - 08/2006
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2014
5	LeptinIBA 04/2017 - 11/2012
5	15-hydroxyprostaglandin dehydrogenaseIBA 09/2010 - 02/2006
4	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 03/2004
4	FructoseIBA 01/2021 - 01/2021
4	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2016
4	Estrogen ReceptorsIBA 01/2020 - 01/2018
4	LipidsIBA 12/2018 - 12/2006
4	LigandsIBA 01/2018 - 07/2004
4	AdiponectinIBA 01/2018 - 11/2012
4	Glucose (Dextrose)FDA LinkGeneric 06/2017 - 01/2016
4	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2014 - 07/2008
4	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 06/2014 - 11/2008
4	Matrix Metalloproteinases (MMPs)IBA 01/2014 - 02/2006
4	ErbB Receptors (EGF Receptor)IBA 10/2007 - 01/2005
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2021
3	HDL CholesterolIBA 01/2021 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2012
3	Phenobarbital (Luminal)FDA Link 12/2018 - 09/2016
3	Biological ProductsIBA 01/2018 - 04/2012
3	Insulin (Novolin)FDA Link 04/2017 - 11/2012
3	CytokinesIBA 01/2016 - 02/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 02/2006
3	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 06/2014 - 11/2008
3	Toll-Like Receptor 4IBA 11/2013 - 09/2006
3	human ERBB2 proteinIBA 10/2013 - 10/2002
3	EicosanoidsIBA 07/2013 - 01/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2009 - 05/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	NucleotidesIBA 01/2021 - 09/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2019 - 10/2007
2	AdipokinesIBA 12/2015 - 01/2013
2	Benzo(a)pyreneIBA 06/2014 - 04/2012
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2014 - 11/2008
2	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 07/2013 - 04/2009

Therapy/Procedure

13	Therapeutics 01/2021 - 06/2005
8	Chemoprevention 01/2016 - 01/2005
7	Mastectomy (Mammectomy) 01/2022 - 01/2016
4	Caloric Restriction 01/2022 - 04/2013
3	Drug Therapy (Chemotherapy) 05/2013 - 08/2002
2	Gastroplasty (Vertical-Banded Gastroplasty) 01/2021 - 01/2021
2	Bariatric Surgery 01/2019 - 06/2017
2	Diet Therapy (Therapy, Diet) 12/2016 - 11/2012